CN1533273A - 紫杉烷类药物的节拍式给药 - Google Patents

紫杉烷类药物的节拍式给药 Download PDF

Info

Publication number
CN1533273A
CN1533273A CNA028090306A CN02809030A CN1533273A CN 1533273 A CN1533273 A CN 1533273A CN A028090306 A CNA028090306 A CN A028090306A CN 02809030 A CN02809030 A CN 02809030A CN 1533273 A CN1533273 A CN 1533273A
Authority
CN
China
Prior art keywords
taxanes
taxane
oral
formula
metronomic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028090306A
Other languages
English (en)
Chinese (zh)
Inventor
J
J·法尼奥利
W·C·罗斯
P·特雷尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CN1533273A publication Critical patent/CN1533273A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
CNA028090306A 2001-02-28 2002-02-26 紫杉烷类药物的节拍式给药 Pending CN1533273A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
US60/271,944 2001-02-28

Publications (1)

Publication Number Publication Date
CN1533273A true CN1533273A (zh) 2004-09-29

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028090306A Pending CN1533273A (zh) 2001-02-28 2002-02-26 紫杉烷类药物的节拍式给药

Country Status (31)

Country Link
EP (1) EP1372636B1 (https=)
JP (1) JP2004538253A (https=)
KR (1) KR20030086276A (https=)
CN (1) CN1533273A (https=)
AR (1) AR033609A1 (https=)
AT (1) ATE331511T1 (https=)
BG (1) BG108167A (https=)
BR (1) BR0207519A (https=)
CA (1) CA2439299A1 (https=)
CY (1) CY1105468T1 (https=)
CZ (1) CZ20032232A3 (https=)
DE (2) DE60212813T2 (https=)
DK (1) DK1372636T3 (https=)
EE (1) EE200300413A (https=)
ES (1) ES2211374T3 (https=)
HR (1) HRP20030775A2 (https=)
HU (1) HUP0402115A2 (https=)
IL (1) IL157356A0 (https=)
IS (1) IS6924A (https=)
MX (1) MXPA03007655A (https=)
NO (1) NO20033809L (https=)
PE (1) PE20020955A1 (https=)
PL (1) PL373376A1 (https=)
PT (1) PT1372636E (https=)
RU (1) RU2003129233A (https=)
SK (1) SK10332003A3 (https=)
TR (1) TR200400375T3 (https=)
UY (1) UY27185A1 (https=)
WO (1) WO2002067928A2 (https=)
YU (1) YU66603A (https=)
ZA (1) ZA200306450B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
PL2286794T3 (pl) * 2003-10-15 2016-10-31 Zastosowanie kationowych liposomów zawierających paklitaksel
JP5700909B2 (ja) * 2005-05-04 2015-04-15 メディゲーネ アクチエンゲゼルシャフトMediGene AG パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
DK1372636T3 (da) 2006-11-06
NO20033809D0 (no) 2003-08-27
SK10332003A3 (sk) 2005-03-04
ES2211374T1 (es) 2004-07-16
CA2439299A1 (en) 2002-09-06
CZ20032232A3 (en) 2004-06-16
BG108167A (en) 2004-09-30
JP2004538253A (ja) 2004-12-24
IL157356A0 (en) 2004-02-19
PE20020955A1 (es) 2002-10-30
ZA200306450B (en) 2004-11-19
DE60212813D1 (de) 2006-08-10
DE02723255T1 (de) 2004-07-15
WO2002067928A2 (en) 2002-09-06
TR200400375T3 (tr) 2004-04-21
WO2002067928A3 (en) 2003-10-09
EP1372636A2 (en) 2004-01-02
AR033609A1 (es) 2003-12-26
IS6924A (is) 2003-08-22
ATE331511T1 (de) 2006-07-15
YU66603A (sh) 2006-08-17
UY27185A1 (es) 2002-09-30
ES2211374T3 (es) 2007-03-01
KR20030086276A (ko) 2003-11-07
RU2003129233A (ru) 2005-02-10
EP1372636B1 (en) 2006-06-28
PT1372636E (pt) 2006-09-29
NO20033809L (no) 2003-10-23
CY1105468T1 (el) 2010-04-28
PL373376A1 (en) 2005-08-22
BR0207519A (pt) 2005-03-08
HRP20030775A2 (en) 2005-02-28
MXPA03007655A (es) 2003-12-04
DE60212813T2 (de) 2007-01-18
HUP0402115A2 (hu) 2005-02-28
EE200300413A (et) 2003-12-15

Similar Documents

Publication Publication Date Title
EP2744773B1 (en) Fluorinated bisphenol ether compounds and methods for their use
TW200942233A (en) Compositions of hydrophobic taxane derivatives and uses thereof
US20220313642A1 (en) Tyrosine derivatives and compositions comprising them
CN1277553A (zh) 血管生成促进剂和血管生成增效剂
CN1466464A (zh) 癌症治疗药
US8242166B2 (en) C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes
US20040143004A1 (en) Metronomic dosing of taxanes
JP2011512399A (ja) 卵巣癌を治療するための、パクリタキセルを含む配合剤
FR2945212A1 (fr) Combinaison antitumorale comprenant le cabazitaxel et la capecitabine
CN1533273A (zh) 紫杉烷类药物的节拍式给药
CN103965175A (zh) 4-(取代苯氨基)喹唑啉类化合物、其制备方法及应用
RU2697551C2 (ru) Новые производные peg
JP2010509306A5 (https=)
JP2020530471A (ja) MEK/PI3K、JAK/MEK、JAK/PI3K/mTORおよびMEK/PI3K/mTORの生物学的経路の阻害剤、および治療化合物のリンパ取り込み、生物学的利用能、および溶解性を改善する方法
JP2013503908A5 (https=)
CN117693517A (zh) 用于靶向治疗肾癌的新型化合物和组合物
CN1380882A (zh) 作为抗肿瘤剂的c10酯取代的紫杉烷
JP2008538099A5 (https=)
CN1490329A (zh) 咪唑啉取代的苯氧乙酰寡肽类衍生物,它们的合成及在医学中的应用
JP6488280B2 (ja) タキサン系化合物を含有する抗腫瘍剤及び抗腫瘍効果増強剤
EP1623706A2 (en) Metronomic dosing of taxanes for inhibiting tumor growth
CN1678310A (zh) 用于治疗良性和恶性肿瘤疾病的含有disorazole及其衍生物的药物
AU2002254048A1 (en) Metronomic dosing of taxanes for inhibiting tumor growth
RU2419622C2 (ru) Производные таксола с противоопухолевой активностью
CN116850187A (zh) Hapalindole在制备抑制肝癌或乳腺癌的药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication